GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » ROE % Adjusted to Book Value

Synthetic MR AB (XSAT:SYNT) ROE % Adjusted to Book Value : 1.28% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB ROE % Adjusted to Book Value?

Synthetic MR AB's ROE % for the quarter that ended in Mar. 2024 was 11.59%. Synthetic MR AB's PB Ratio for the quarter that ended in Mar. 2024 was 9.02. Synthetic MR AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 1.28%.


Synthetic MR AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Synthetic MR AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB ROE % Adjusted to Book Value Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.04 0.35 0.58 0.94

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 1.37 1.66 1.69 1.28

Competitive Comparison of Synthetic MR AB's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Synthetic MR AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's ROE % Adjusted to Book Value falls into.



Synthetic MR AB ROE % Adjusted to Book Value Calculation

Synthetic MR AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.95% / 9.50
=0.94%

Synthetic MR AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.59% / 9.02
=1.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthetic MR AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel Inc. (SYNT) Chairman, 10% Owner Bharat Desai sells 2,610,000 Shares

By GuruFocus Research GuruFocus Editor 11-22-2010

Interim CEO Invests in IT Company

By Jennifer Chiou Jennifer Chiou 12-07-2016

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017

Syntel enters definitive agreement to be acquired by Atos S.E.

By Marketwired Marketwired 07-22-2018

Syntel Inc. (SYNT) CEO and President Prashant Ranade sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 12-21-2010

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018